Emergence of a novel mutant PCV2b variant associated with clinical PCVAD in two vaccinated pig farms in the U.S. concurrently infected with PPV2

Veterinary Microbiology

Volumn 163, Issue 1-2, 2013, Pages 177-183

  Opriessnig, Tanja ^a   Xiao, Chao Ting ^a   Gerber, Priscilla F ^a   Halbur, Patrick G ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Mutant PCV2; Porcine circovirus type 2 (PCV2); Porcine parvovirus type 2 (PPV2); Vaccination

Indexed keywords

CIRCOVIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CIRCOVIRIDAE INFECTION; CIRCOVIRUS; CIRCOVIRUS TYPE 2A; CIRCOVIRUS TYPE 2B; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC VARIABILITY; GENOME ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PIG FARMING; PROTECTION; VACCINATION; VIREMIA; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; CHINA; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; GENES, VIRAL; MOLECULAR SEQUENCE DATA; PARVOVIRIDAE INFECTIONS; PARVOVIRUS, PORCINE; SEQUENCE ALIGNMENT; SWINE; SWINE DISEASES; UNITED STATES; VIRAL VACCINES;

PORCINE CIRCOVIRUS 2; PORCINE CIRCOVIRUS TYPE 2-B; PORCINE PARVOVIRUS; SUIDAE;

EID: 84874558397     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2012.12.019     Document Type: Article

References (35)

1. Allan G.M., Kennedy S., McNeilly F., Foster J.C., Ellis J.A., Krakowka S.J., Meehan B.M., Adair B.M. Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus. J. Comp. Pathol. 1999, 121:1-11.
2. Cadar D., Cságola A., Lorincz M., Tombácz K., Spînu M., Tuboly T. Detection of natural inter- and intra-genotype recombination events revealed by cap gene analysis and decreasing prevalence of PCV2 in wild boars. Infect. Genet. Evol. 2012, 12:420-427.
3. Cortey M., Olvera A., Grau-Roma L., Segalés J. Further comments on porcine circovirus type 2 (PCV2) genotype definition and nomenclature. Vet. Microbiol. 2011, 149:522-523.
4. Cságola A., Lörincz M., Cadar D., Tombacz K., Biksi I., Tuboly T. Detection, prevalence and analysis of emerging porcine parvovirus infections. Arch. Virol. 2012, 157:1003-1010.
5. Cheung A.K., Lager K.M., Kohutyuk O.I., Vincent A.L., Henry S.C., Baker R.B., Rowland R.R., Dunham A.G. Detection of two porcine circovirus type 2 genotypic groups in United States swine herds. Arch. Virol. 2007, 152:1035-1044.
6. Cheung A.K., Wu G., Wang D., Bayles D.O., Lager K.M., Vincent A.L. Identification and molecular cloning of a novel porcine parvovirus. Arch. Virol. 2010, 155:801-806.
7. Fachinger V., Bischoff R., Jedidia S.B., Saalmüller A., Elbers K. The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex. Vaccine 2008, 26:1488-1499.
8. Fort M., Sibila M., Allepuz A., Mateu E., Roerink F., Segalés J. Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins. Vaccine 2008, 26:1063-1071.
9. Fraile L., Grau-Roma L., Sarasola P., Sinovas N., Nofrarías M., López-Jimenez R., López-Soria S., Sibila M., Segalés J. Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: improvement of production parameters and interaction with maternally derived immunity. Vaccine 2012, 30:1986-1992.
10. Gagnon C.A., Music N., Fontaine G., Tremblay D., Harel J. Emergence of a new type of porcine circovirus in swine (PCV): a type 1 and type 2 PCV recombinant. Vet. Microbiol. 2010, 144:18-23.
11. Gagnon C.A., Tremblay D., Tijssen P., Venne M.H., Houde A., Elahi S.M. The emergence of porcine circovirus 2b genotype (PCV-2b) in swine in Canada. Can. Vet. J. 2007, 48:811-819.
12. Guo L., Fu Y., Wang Y., Lu Y., Wei Y., Tang Q., Fan P., Liu J., Zhang L., Zhang F., Huang L., Liu D., Li S., Wu H., Liu C. A porcine circovirus type 2 (PCV2) mutant with 234 amino acids in capsid protein showed more virulence in vivo, compared with classical PCV2a/b strain. PLoS One 2012, 7:e41463.
13. Guo L., Lu Y., Wei Y., Huang L., Wu H., Liu C. Porcine circovirus genotype 2a (PCV2a) and genotype 2b (PCV2b) recombinant mutants showed significantly enhanced viral replication and altered antigenicity in vitro. Virology 2011, 419:57-63.
14. Guo L.J., Lu Y.H., Wei Y.W., Huang L.P., Liu C.M. Porcine circovirus type 2 (PCV2): genetic variation and newly emerging genotypes in China. Virol. J. 2010, 7:273.
15. Hijikata M., Abe K., Win K.M., Shimizu Y.K., Keicho N., Yoshikura H. Identification of new parvovirus DNA sequence in swine sera from Myanmar. Jpn. J. Infect. Dis. 2001, 54:244-245.
16. Horlen K.P., Dritz S.S., Nietfeld J.C., Henry S.C., Hesse R.A., Oberst R., Hays M., Anderson J., Rowland R.R. A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2. J. Am. Vet. Med. Assoc. 2008, 232:906-912.
17. Huang L., Zhai S.L., Cheung A.K., Zhang H.B., Long J.X., Yuan S.S. Detection of a novel porcine parvovirus, PPV4, in Chinese swine herds. Virol J. 2010, 21(7):333.
18. Khayat R., Brunn N., Speir J.A., Hardham J.M., Ankenbauer R.G., Schneemann A., Johnson J.E. The 2.3-angstrom structure of porcine circovirus 2. J. Virol. 2011, 85:7856-7862.
19. Kixmöller M., Ritzmann M., Eddicks M., Saalmüller A., Elbers K., Fachinger V. Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2. Vaccine 2008, 26:3443-3451.
20. Kumar S., Gadagkar S.R. Efficiency of the neighbor-joining method in reconstructing deep and shallow evolutionary relationships in large phylogenies. J. Mol. Evol. 2000, 51:544-553.
21. Lau S.K., Woo P.C., Tse H., Fu C.T., Au W.K., Chen X.C., Tsoi H.W., Tsang T.H., Chan J.S., Tsang D.N., Li K.S., Tse C.W., Ng T.K., Tsang O.T., Zheng B.J., Tam S., Chan K.H., Zhou B., Yuen K.Y. Identification of novel porcine and bovine parvoviruses closely related to human parvovirus 4. J. Gen. Virol. 2008, 89:1840-1848.
22. Martelli P., Ferrari L., Morganti M., De Angelis E., Bonilauri P., Guazzetti S., Caleffi A., Borghetti P. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions. Vet. Microbiol. 2011, 149:339-351.
23. Nawagitgul P., Harms P.A., Morozov I., Thacker B.J., Sorden S.D., Lekcharoensuk C., Paul P.S. Modified indirect porcine circovirus (PCV) type 2-based and recombinant capsid protein (ORF2)-based enzyme-linked immunosorbent assays for detection of antibodies to PCV. Clin. Diagn. Lab. Immunol. 2002, 9:33-40.
24. Opriessnig T., Fenaux M., Yu S., Evans R.B., Cavanaugh D., Gallup J.M., Pallares F.J., Thacker E.L., Lager K.M., Meng X.J., Halbur P.G. Effect of porcine parvovirus vaccination on the development of PMWS in segregated early weaned pigs coinfected with type 2 porcine circovirus and porcine parvovirus. Vet. Microbiol. 2004, 98:209-220.
25. Opriessnig T., Halbur P.G. Concurrent infections are important for expression of porcine circovirus associated disease. Virus Res. 2012, 164:20-32.
26. Opriessnig T., Patterson A.R., Madson D.M., Pal N., Halbur P.G. Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV-PCV2-SIV clinical infection model 2-3-months post vaccination. Vaccine 2009, 27:1002-1007.
27. Opriessnig T., Prickett J.R., Madson D.M., Shen H.G., Juhan N.M., Pogranichniy R.R., Meng X.J., Halbur P.G. Porcine circovirus type 2 (PCV2)-infection and re-inoculation with homologous or heterologous strains: virological, serological, pathological and clinical effects in growing pigs. Vet. Res. 2010, 41:31.
28. Opriessnig T., Yu S., Gallup J.M., Evans R.B., Fenaux M., Pallarés F.J., Thacker E.L., Brockus C.W., Ackermann M.R., Thomas P., Meng X.J., Halbur P.G. Effect of vaccination with selective bacterins on conventional pigs infected with type 2 porcine circovirus. Vet. Pathol. 2003, 40:521-529.
29. Patterson A.R., Opriessnig T. Epidemiology and horizontal transmission of porcine circovirus type 2 (PCV2). Anim. Health Res. Rev. 2010, 11:217-234.
30. Shen H.G., Beach N., Huang Y.W., Halbur P.G., Meng X.J., Opriessnig T. Comparison of commercial and experimental porcine circovirus type 2 (PCV2) vaccines using a triple challenge with PCV2, porcine reproductive and respiratory syndrome virus (PRRSV), and porcine parvovirus (PPV). Vaccine 2010, 28:5960-5966.
31. Shen H.G., Halbur P.G., Opriessnig T. Prevalence and phylogenetic analysis of the current PCV2 genotypes after implementation of widespread vaccination programs in the United States. J. Gen. Virol. 2012, 1345-1355.
32. Takahagi Y., Toki S., Nishiyama Y., Morimatsu F., Murakami H. Differential effects of porcine circovirus type 2 (PCV2) vaccination on PCV2 genotypes at Japanese pig farms. J. Vet. Med. Sci. 2009, 72:35-41.
33. Wang F., Wei Y., Zhu C., Huang X., Xu Y., Yu L., Yu X. Novel parvovirus sublineage in the family of Parvoviridae. Virus Genes 2010, 41:305-308.
34. Xiao C.T., Gerber P.F., Giménez-Lirola L.G., Halbur P.G., Opriessnig T. Characterization of porcine parvovirus type 2 (PPV2) which is highly prevalent in the USA. Vet. Microbiol. 2013, 161:325-330.
35. Xiao C.T., Giménez-Lirola L.G., Halbur P.G., Opriessnig T. Increasing porcine PARV4 prevalence with pig age in the U.S. pig population. Vet. Microbiol. 2012, 160:290-296.